---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-26-000055"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2026-07-23T20:01:19+00:00"
generated_at: "2026-07-23T20:02:15.983805+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma issues 4.7M shares in partial over-allotment exercise, raising $1.5M gross

## Summary
- On July 23, 2026, issued 4,696,102 shares of Class A common stock to underwriters.
- Gross proceeds of approximately $1.5 million; net proceeds of ~$1.4 million after underwriting discounts.
- Partial exercise of over-allotment option; previous full exercise for warrants to purchase 6,403,290 shares.
- Offering originally completed July 15, 2026, with Lake Street Capital Markets as representative.

## SEC filing metadata
- accession: 0001837607-26-000055
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2026-07-23T20:01:19+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/0001837607-26-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000055/aeon-20260723x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-26-000055
- JSON: https://secwatch.observer/filing/0001837607-26-000055.json
- Plain text: https://secwatch.observer/filing/0001837607-26-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.